Project Details
Description
N91115-2CF-05 (SNO-6): A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the
Status | Finished |
---|---|
Effective start/end date | 9/15/15 → 12/31/16 |
Funding
- NIVALIS THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.